Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed/Refractory Diffuse Large B Cell Lymphoma

Clinical trial condition

Relapsed/Refractory Diffuse Large B Cell Lymphoma

Explore clinical trials studying Relapsed/Refractory Diffuse Large B Cell Lymphoma. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed/Refractory Diffuse Large B Cell Lymphoma trial results

Recruiting

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

NCT07451652

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Hospital Universitario "Dr. José Eleuterio González" Monterrey, Nuevo León, Mexico

View Trial Details

Active, Not Recruiting

Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation Combined With Tafasitamab, Lenalidomide, and Standard Immunochemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT07621406

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Active, Not Recruiting

GPL in Patients with Relapsed/refractory Diffuse Large B Cell Lymphoma

NCT05335018

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details